课题基金 / 基金详情

New molecular targeting therapy for regression of cardiac hypertrophy by inhibiting abnormal Ca2+ leak through RyR2 in hypertrophic cardiomyopathy

New molecular targeting therapy for regression of cardiac hypertrophy by inhibiting abnormal Ca2+ leak through RyR2 in hypertrophic cardiomyopathy
通过 RyR2 抑制异常 Ca2 渗漏来消退肥厚型心肌病的新型分子靶向治疗
批准号:
26670404
负责人:
YANO Masafumi
金额:
$2.33万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Challenging Exploratory Research
财政年份:
2014
资助国家:
日本
项目状态:
已结题
起止时间:
2014-04-01 至 2016-03-31

项目摘要

项目成果

YANO Masafumi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
期刊论文(17)
专著(0)
科研奖励(0)
会议论文
RyR2 stabilization by inhibiting aberrant Ca2+ release mediated by CaMKII signaling and Ca2+ buffering function suppresses arrhythmogenesis in Troponin T-related familial hypertrophic cardiomyopathy
RyR2 通过抑制 CaMKII 信号传导和 Ca2 缓冲功能介导的异常 Ca2 释放来稳定,从而抑制肌钙蛋白 T 相关家族性肥厚型心肌病的心律失常发生
DOI: --
发表时间: 2015
期刊:
影响因子: --
作者: [Okuda S, Kato T, Fukuda M, Nichimura S, Kobayashi S, Oda T, Yamamoto T, Yano M]
通讯作者: Yano M
High Affinity CaM, but Not Normal Affinity CaM Can Prevent Arrhythmias in CPVT Which Mutation is Located at CaM-like Domain of RyR2.
高亲和力CaM而非普通亲和力CaM可以预防CPVT中的心律失常,其突变位于RyR2的CaM样结构域。
DOI: --
发表时间: 2015
期刊:
影响因子: --
作者: [Nishimura S, Yamamoto T, Fukui G, Maeda T, Hino A, Suetomi T, Ono M, Mochozuki M, Oda T, Okuda S, Kobayashi S, Yano M]
通讯作者: Yano M
Dantrolene Cannot Inhibit Aberrant Ca2+ Release and Arrhythmias Without Calmodulin in Pressure Overload Heart Failure
在没有钙调蛋白的情况下,丹曲林无法抑制压力过载心力衰竭中的异常 Ca2 释放和心律失常
DOI: --
发表时间: 2015
期刊:
影响因子: --
作者: [Zhan H, Aizawa K, Sun JQ, Tomida S, Otsu K, Conway S, McKinnon P, Manabe I, Komuro I, Miyagawa K, Nagai R, Suzuki T, Go Fukui,Takeshi Yamamoto,Tkayoshi Kato,Takako Maeda,Shigehiko Nishimura,Akihiro Hino,Takeshi Suetomi,Makoto Ono,Mamoru Mochizuki,Tetsuro Oda,Shinichi Okuda,Shigeki Kobayashi,Masafumi Yano]
通讯作者: Go Fukui,Takeshi Yamamoto,Tkayoshi Kato,Takako Maeda,Shigehiko Nishimura,Akihiro Hino,Takeshi Suetomi,Makoto Ono,Mamoru Mochizuki,Tetsuro Oda,Shinichi Okuda,Shigeki Kobayashi,Masafumi Yano
DOI: 10.1016/j.bbrc.2014.03.152
发表时间: 2014-05-23
期刊: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
影响因子: 3.1
作者: [Fukuda, Masakazu, Yamamoto, Takeshi, Yano, Masafumi]
通讯作者: Yano, Masafumi
15
    Comprehensive treatment of heart failure, cardiac hypertrophy, and arrhythmia by controlling ryanodine receptor bound calmodulin
    • 批准号:
      17H04178
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.73万
    • 财政年份:
      2017
    • 负责人:
      YANO Masafumi
    • 依托单位:
    An attempt to regress cardiac hypertrophy by cardiomyocyte intracellular calmodulin control
    • 批准号:
      16K15443
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.25万
    • 财政年份:
      2016
    • 负责人:
      YANO Masafumi
    • 依托单位:
    Comprehensive strategy of heart failure, cardiac hypertrophy and lethal arrhythmia via stabilizing the stricture of ryanodine receptor
    • 批准号:
      26293189
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.65万
    • 财政年份:
      2014
    • 负责人:
      YANO Masafumi
    • 依托单位:
    Development of comprehensive treatment of heart failure, hypertrophy, and arrhythmia by regulating intracellular Ca
    • 批准号:
      23390215
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.31万
    • 财政年份:
      2011
    • 负责人:
      YANO Masafumi
    • 依托单位:
    海外基金